Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Public Health ; 118(3): 225-9, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15003412

ABSTRACT

The purpose of this study was to compare total capillary, total venous, risk ratio, high-density lipoprotein and low-density lipoprotein measures of cholesterol to determine whether total capillary cholesterol is a valid measure to use in cholesterol screening. An announcement and a registration form were distributed with employee paychecks announcing a cholesterol-screening programme. Capillary and venous samples were collected from screening participants (n=285). Results indicated false negatives in total capillary cholesterol in 17.21-34.4% of cases compared with other methods of cholesterol measurement. Due to the high number of misclassifications, health educators should not use total capillary cholesterol as a predictor of risk for heart disease, nor as a measure for referral during cholesterol screenings.


Subject(s)
Hypercholesterolemia/diagnosis , Adult , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Female , Health Promotion , Humans , Hypercholesterolemia/blood , Male , Middle Aged , Public Health , Risk Assessment , United States
2.
Oncologist ; 6 Suppl 2: 29-32, 2001.
Article in English | MEDLINE | ID: mdl-11331438

ABSTRACT

Approximately 20%-30% of patients with acute promyelocytic leukemia (APL) who are treated with the current standard all-trans retinoic acid and anthracycline-based chemotherapy regimen suffer relapse. In the mid-1990s, studies from China reported the effective use of arsenic trioxide in achieving complete remission in patients with APL. In the United States, a multicenter trial of this agent in 40 patients with relapsed APL following conventional therapy confirmed the positive safety and efficacy outcomes of a smaller 12-patient pilot study. Common adverse events were hyperleukocytosis, APL differentiation syndrome, prolonged QT interval on electrocardiogram, skin rash, and hyperglycemia.


Subject(s)
Antineoplastic Agents , Arsenicals , Leukemia, Promyelocytic, Acute/drug therapy , Oxides , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Arsenic Trioxide , Arsenicals/adverse effects , Arsenicals/therapeutic use , Humans , Neoplasm Recurrence, Local , Oxides/adverse effects , Oxides/therapeutic use , Risk Assessment
3.
Semin Oncol Nurs ; 16(2): 152-62, 2000 May.
Article in English | MEDLINE | ID: mdl-10842785

ABSTRACT

OBJECTIVES: To provide information on the assessment and management of the nutritional needs of patients with severe neutropenia. DATA SOURCES: Textbook chapters, research articles, and review articles. CONCLUSIONS: Malnutrition is a common result of high-dose chemotherapy treatment. Clinical outcomes are directly related to careful assessment, early intervention, and ongoing evaluation and monitoring in the severely neutropenic population. IMPLICATIONS FOR NURSING PRACTICE: Early assessment, management, and psychological support are essential in meeting the needs of this patient population.


Subject(s)
Neoplasms/nursing , Neutropenia/nursing , Neutropenia/physiopathology , Nutrition Disorders/prevention & control , Nutritional Support/nursing , Humans , Nutrition Assessment , Nutrition Disorders/nursing , Oncology Nursing , Severity of Illness Index
4.
Percept Mot Skills ; 90(1): 105-10, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10769888

ABSTRACT

The relationship of sex composition of class and instructor's sex to Physical Self-efficacy has yielded conflicting results in several studies. This study examined the relationship of sex composition of class and instructor's sex to scores on Physical Self-efficacy, Perceived Physical Ability, and Physical Self-presentation Confidence of 80 male students enrolled in one of four sections of a strength training class. Analysis indicated no significant difference on Physical Self-efficacy between male students who were enrolled in all male classes or in coeducational classes; improvements in scores on Physical Self-efficacy were not specific to the sex composition of the class or sex of the instructor and no significant difference on Perceived Physical Ability and Physical Self-presentation Confidence between male students who joined an all male class or a coeducational class. Perceived Physical Ability improved from the pretest to the posttest in all classes; and no improvement in scores for Physical Self-presentation Confidence was found in all classes. In conclusion, the analysis showed sex composition of the class and sex of the instructor were not significantly related to scores for self-efficacy.


Subject(s)
Physical Fitness , Self Efficacy , Sex Distribution , Students/statistics & numerical data , Teaching/statistics & numerical data , Female , Humans , Male , Muscle Contraction/physiology , Personality Inventory , Physical Education and Training/statistics & numerical data , Physical Exertion/physiology , Sex Factors , Students/psychology , Surveys and Questionnaires
5.
Clin J Oncol Nurs ; 3(2): 57-62, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10633612

ABSTRACT

Oprelvekin (Neumega, Genetic Institute Co., Cambridge, MA) is a thrombopoietic growth factor approved by the U.S. Food and Drug Administration for the prevention of severe thrombocytopenia following myelosuppressive chemotherapy in patients with nonmyeloid malignancies. The most common side effects are edema, dyspnea, tachycardia, and conjunctival redness. Patient-care concerns include appropriate timing of administration, patient selection, dosing and administration issues, and the early identification and management of side effects.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Interleukin-11/therapeutic use , Thrombocytopenia/chemically induced , Thrombocytopenia/therapy , Antineoplastic Agents/adverse effects , Female , Humans , Interleukin-11/adverse effects , Middle Aged , Patient Care Planning , Patient Education as Topic , Patient Selection , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , United States , United States Food and Drug Administration
6.
Clin J Oncol Nurs ; 3(4): 153-60, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10703321

ABSTRACT

Anemia is not an uncommon problem. Knowledge of a few common laboratory tests can be helpful when caring for patients with anemia. By reviewing approaches to classifying, evaluating, and managing patients with common anemias, nurses will be prepared to care for patients with an anemia more confidently.


Subject(s)
Anemia/diagnosis , Anemia/nursing , Nursing Assessment/methods , Anemia/blood , Anemia/etiology , Diagnosis, Differential , Humans , Medical History Taking/methods , Patient Care Planning , Physical Examination/methods , Risk Factors
7.
Oncol Nurs Forum ; 25(1): 35-48, 1998.
Article in English | MEDLINE | ID: mdl-9460772

ABSTRACT

PURPOSE/OBJECTIVES: To review the drug profile and nursing implications associated with the new lipid amphotericin preparations. DATA SOURCES: Published articles, abstracts, professional communications, drug manufacturer prescribing information, and personal experience. DATA SYNTHESIS: Three lipid amphotericin B (AmB) preparations have been approved by the U.S. Food and Drug Administration (FDA). The first agent, amphotericin B lipid complex (Abelcet, Liposome Co., Princeton, NJ), a ribbon-like structure, was approved in November 1995 for the treatment of aspergillosis in patients who are refractory to or intolerant of conventional amphotericin B therapy and for invasive fungal infections. In November 1996, amphotericin B cholesteryl sulfate complex for injection (Amphotec, Sequus Pharmaceuticals, Menlo Park, CA), a second preparation composed of a disc-like structure, received FDA approval for the treatment of invasive aspergillosis in patients in whom renal impairment or unacceptable toxicity precludes the use of conventional AmB therapy and in patients in whom prior AmB therapy has failed. Amphotec frequently is referred to as amphotericin B colloidal dispersion (ABCD). The third formulation, a liposomal preparation composed of vesicles, liposomal amphotericin B or L-AmB (AmBisome, Fujisawa USA, Inc., Deerfield, IL, and Nexstar Co., Boulder, CO) recently received FDA approval for three indications. All of these preparations accumulate in organs of the reticuloendothelial system as opposed to the kidneys. Further studies of lipid AmB are needed to help clarify the usefulness of each AmB preparation. The most common side effects of lipid AmB preparations are chills and fever. CONCLUSIONS: Lipid-based AmB preparations are well-tolerated treatments with mild to moderate side effects. These preparations have some advantages over conventional AmB. IMPLICATIONS FOR NURSING PRACTICE: Nurses in clinical settings can focus on staff and patient education, including identification and management of side effects associated with the lipid-based AmB preparations. Patient-care concerns include appropriate patient selection, dosing and administration issues, and the prevention, early identification, and management of toxicities.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Drug Delivery Systems , Amphotericin B/administration & dosage , Amphotericin B/adverse effects , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Clinical Trials as Topic , Drug Carriers , Drug Combinations , Humans , Liposomes , Patient Care Planning , Phosphatidylcholines , Phosphatidylglycerols
8.
Am J Occup Ther ; 49(3): 214-20, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7741154

ABSTRACT

OBJECTIVE: This preliminary study was designed to determine whether occupational therapists involve patients and their families in a goal-setting process and, if so, to identify the methods used. METHOD: Thirty registered occupational therapists practicing in adult physical rehabilitation settings were audiotaped during an initial evaluation. Researchers reviewed corresponding documentation and interviewed each subject. Twenty-three patient and family involvement criteria were generated from standards developed by accreditation commissions and health care professions. RESULTS: Data revealed that although subjects did involve patients and families in a goal-setting process, a number of criteria were not attempted, thus much potential for involvement was unrealized. Subjects with scores above and below one standard deviation from the mean were identified to determine which patient participation criteria had the highest discrepancies. Discrepancies included (a) verbal preparation of the patient and family for initial and ongoing treatment, purposes and procedures of evaluation and treatment, and potential outcomes of treatment, (b) attempts to elicit the patient's concerns, and (c) collaboration with the patient to establish treatment goals. CONCLUSION: Factors that might have influenced subjects' use of a patient participation approach included the application of a specific theory or technique, time constraints, patient's age, and assumptions about the patient's cognitive status.


Subject(s)
Goals , Occupational Therapy/methods , Patient Participation , Adult , Caregivers , Female , Humans , Male
9.
Adv Space Res ; 12(2-3): 289-301, 1992.
Article in English | MEDLINE | ID: mdl-11537019

ABSTRACT

This is a survey of solar phenomena and physical models that may be useful for improving forecasts of solar flares and proton storms in interplanetary space. Knowledge of the physical processes that accelerate protons has advanced because of gamma-ray and X-ray observations from the Solar Maximum Mission telescopes. Protons are accelerated at the onset of flares, but the duration of any subsequent proton storm at 1 AU depends on the structure of the interplanetary fields. X-ray images of the solar corona show possible fast proton escape paths. Magnetographs and high-resolution visible-band images show the magnetic field structure near the acceleration region and the heating effects of sunward-directed protons. Preflare magnetic field growth and shear may be the most important clues to the physical processes that generate high energy solar particles. Any dramatic improvement in flare forecasts will require high resolution solar telescopes in space. Several possibilities for improvements in the art of flare forecasting are presented, among them: the use of acoustic tomography to probe for subsurface magnetic fields; a satellite-borne solar magnetograph; and an X-ray telescope to monitor the corona for eruptions.


Subject(s)
Extraterrestrial Environment , Magnetics , Protons , Solar System , Astronomical Phenomena , Astronomy , Physical Phenomena , Physics
10.
Appl Opt ; 26(13): 2637-42, 1987 Jul 01.
Article in English | MEDLINE | ID: mdl-20489934

ABSTRACT

Observations of nonradial solar oscillations require Doppler velocity measurement at many points over the photosphere with a velocity resolution better than 1 m/s. An attractive form of imaging spectrophotometer for such a task utilizes a thin, solid, electrically tunable Fabry-Perot interference filter or etalon made of an electrooptic material such as lithium niobate (LiNbO(3)). The problems to be overcome in producing such an etalon for an imaging spectrophotometer are discussed and practical solutions demonstrated on the basis of measurements made on prototype devices.

11.
Science ; 216(4549): 939-46, 1982 May 28.
Article in English | MEDLINE | ID: mdl-17809050

ABSTRACT

The space shuttle era will focus renewed attention on the hazards of the space environment to human habitation. The chief unpredictable hazard for astronauts is energetic proton radiation from solar flares. In some orbits, there is no reasonable level of shielding material that will protect shuttle occupants from potentially lethal doses of radiation. The effects of a solar flare that occurred druing the first flight of the Columbia are discussed and current flare research reviewed. The emphasis is on progress made during the recent international Solar Maximum Year toward understanding the origins of proton showers.

SELECTION OF CITATIONS
SEARCH DETAIL
...